SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits

By sjmartinez • October 11, 2022

Dixit NM, Ziaeian B, Fonarow GC. SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits. Heart Fail Clin. 2022 Oct;18(4):587-596. doi: 10.1016/j.hfc.2022.03.003. PMID: 36216488.

Tags: Cardiology/Epi, Guideline-directed medical therapy, Heart failure with preserved ejection fraction, Heart failure with reduced ejection fraction, Initiation and sequencing, Publications

ENPP1 blockade with a humanized monoclonal antibody enhances renal repair after acute kidney injury

Su L, Sun Q, Zhou Z, Wang R, Wang J, Alvarez JF, Tao B, Das K, Zhou Q, Wang J, Zhang G, Ten Hoeve J,[...]

Electrophysiological Effects of Right and Left Tragus Nerve Stimulation in Humans

Olarte N, Nguyen H, Krokhaleva Y, Khakpour H, Do D, Hayase J, Macias C, Stavrakis S, Vaseghi M. Electrophysiological Effects of Right and Left Tragus[...]

Purulent Pericarditis and Tamponade From a Migrating Esophageal Foreign Body

Hindosh ZR, Cha BM, Soverow J, Nguyen K. Purulent Pericarditis and Tamponade From a Migrating Esophageal Foreign Body. JACC Case Rep. 2026 Jun 13:108754. doi:[...]